Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous T-cell lymphoma.

E A Kotz1, D Anderson, B H Thiers

  • 1Department of Dermatology, Medical University of South Carolina, Charleston, SC 29425, USA.

Journal of the European Academy of Dermatology and Venereology : JEADV
|April 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Systemic Weber-Christian disease.

Journal of cutaneous medicine and surgery·2001
Same author

Topical tacrolimus: treatment failure in a patient with alopecia areata.

Archives of dermatology·2000
Same author

Dermatology therapy update.

The Medical clinics of North America·1999
Same author

Psoriasis therapy update.

The Western journal of medicine·1998
Same author

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail.

Journal of the American Academy of Dermatology·1998
Same journal

Environmental criteria in dermatology research grants.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Microneedling with adipose MSC exosomes versus monotherapy for androgenetic alopecia.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Diabetes and melanoma: Impact on prognosis and healthcare costs.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Differential survival with adjuvant immunotherapy in stage III acral versus non-acral melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Estimating the global burden of mental health disorders associated with atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Proteomic analysis in hidradenitis suppurativa reveals systemic inflammation in all disease stages.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
See all related articles

Cutaneous T-cell lymphoma (CTCL) is a skin cancer requiring careful diagnosis due to varied presentations. Early detection and staging are crucial for managing this chronic condition and guiding treatment decisions.

Area of Science:

  • Dermatology
  • Oncology
  • Hematology

Background:

  • Cutaneous T-cell lymphoma (CTCL) originates from helper T cells, primarily affecting the skin.
  • CTCL presents with diverse clinical and histopathological features, often making early diagnosis challenging.
  • A high index of suspicion and serial biopsies are sometimes necessary for diagnosing CTCL, especially with non-specific early lesions.

Purpose of the Study:

  • To highlight the diagnostic complexities of Cutaneous T-cell lymphoma (CTCL).
  • To emphasize the importance of accurate staging for treatment and prognosis in CTCL.
  • To review the clinical characteristics, prognostic indicators, and management of CTCL.

Main Methods:

  • Clinical presentation analysis
  • Histopathological evaluation

Related Experiment Videos

  • Staging assessment
  • Review of treatment modalities

    • Main Results:

    • CTCL diagnosis can be difficult due to non-specific early clinical and pathological findings.
    • Tumor development and erythroderma are poor prognostic indicators in CTCL.
    • Sezary syndrome is a severe form of CTCL characterized by specific clinical and cellular features.

    Conclusions:

    • Accurate diagnosis and staging are essential for effective management of Cutaneous T-cell lymphoma.
    • Treatment for CTCL should be individualized, with photochemotherapy and topical chemotherapy being common options.
    • Septicemia remains a significant cause of mortality in advanced CTCL cases.